Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-5-5
pubmed:abstractText
DISC-hGMCSF is a gH-deleted HSV-2 based vector expressing human GM-CSF that has entered clinical trials for the therapy of metastatic melanoma. To determine whether this product also has potential to treat breast carcinoma, a series of in vitro and in vivo studies were made.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1099-498X
pubmed:author
pubmed:copyrightInfo
Copyright 2003 John Wiley & Sons, Ltd.
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
407-16
pubmed:dateRevised
2006-4-21
pubmed:meshHeading
pubmed-meshheading:12731089-Animals, pubmed-meshheading:12731089-Antimetabolites, Antineoplastic, pubmed-meshheading:12731089-Breast Neoplasms, pubmed-meshheading:12731089-Cell Line, Tumor, pubmed-meshheading:12731089-Cell Separation, pubmed-meshheading:12731089-Centrifugation, pubmed-meshheading:12731089-Female, pubmed-meshheading:12731089-Flow Cytometry, pubmed-meshheading:12731089-Fluorouracil, pubmed-meshheading:12731089-Gene Therapy, pubmed-meshheading:12731089-Genetic Vectors, pubmed-meshheading:12731089-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:12731089-Green Fluorescent Proteins, pubmed-meshheading:12731089-Herpesvirus 2, Human, pubmed-meshheading:12731089-Humans, pubmed-meshheading:12731089-Luminescent Proteins, pubmed-meshheading:12731089-Mammary Neoplasms, Animal, pubmed-meshheading:12731089-Mice, pubmed-meshheading:12731089-Mice, Inbred BALB C, pubmed-meshheading:12731089-Phenotype, pubmed-meshheading:12731089-Time Factors
pubmed:year
2003
pubmed:articleTitle
Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.
pubmed:affiliation
Xenova Group plc, 310 Cambridge Science Park, UK. Peter_Loudon@xenova.co.uk
pubmed:publicationType
Journal Article